Back

Coronary artery disease and use of dual or triple antithrombotic therapy in patients with atrial fibrillation: the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Pilot Registry

31 August 2016 (09:00 - 09:06)
Organised by:
Congress Presentation Part of: Risk factors and comorbidities: effects on clinical outcome in coronary artery disease CAD and comorbidities ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

9 More presentations in this session

Presentation thumbnail
Diabetes and time course of adverse events in patients with acute coronary syndromes undergoing percutaneous coronary intervention
Doctor R. Piccolo (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Hemoglobin drop in non-anemic patients with acute myocardial infarction: impact in in-hospital morbidity and mortality
Doctor B. Picarra (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Cardiac troponins, type II myocardial infarction and late mortality: a report from the Australian and New Zealand 2012 SNAPSHOT ACS Study.
Professor J. French (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Living alone and its effect on cardiovascular health: insights from the CLARIFY registry
Doctor S. Gandhi (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Impact of new onset atrial fibrillation in ACS patients: insights from the Swiss AMIS plus registry
Doctor L. Biasco (Cirie, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and comorbidities: effects on clinical outcome in coronary artery disease

The Event

Event poster

ESC Congress 2016

31 August 2016 09:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources